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Background: Bacterial sepsis induced immunsuppression via antigen hyporesponsibility increases the risk of
nosokomial infections and mortality. Pattern recognition receptors (PRR) might have a central role in the
pathophysiology of hyporesponsibility.
Methods: In this study we evaluated in a human E. coli sepsis cohort, the role of PRR including TLR’s and Trem-1.
Expression of Trem-1, TLR2, TLR4, CD14 and HLA-DR on blood monozytes and neutrophils were examined using
flow cytometry from 22 patients with E. coli sepsis and 6 healthy controls. LPS and LTA stimulated TNF alpha, IL-10,
IL-8 and IL-6 production was studied in a 24 h whole blood assay. Free cytokine serum concentration of TNF alpha,
PCT and IP-10 were evaluated.
Results: We found a significant higher expression of Trem-1 and TLR-2 on monocytes and neutrophils in patients
compared to healthy volunteers. TLR2 expression (p < 0.05) was higher and HLA-DR lower (p < 0.05) on monocytes
of patients with severe sepsis compared to patients with simple sepsis. Trem-1 expression was tendentially higher
(p = 0,07) on monocytes and lower on neutrophils of patients with severe sepsis. Trem-1 expression on neutrophils
was associated with the IL-10 (LPS: r = 0,61, p < 0.02) and TNF-α inducibility (LPS: r = 0,78, p < 0,002). In addition
Trem-1 expression on neutrophils shows a negative correlation to the serum levels of TNF alpha (r = −0,63; p <
0,005), IP-10 (r = −0,5; p < 0,035) and procalcitonin (r = −0,59; p < 0,007).
Conclusions: Patients with E. coli sepsis are characterized by an association of Trem-1 expression on blood
neutrophils with cytokine inducibility. The TREM-1 pathway on neutrophils might play a role in producing an
adequate inflammatory and bactericidal response in bacterial sepsis.
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Despite development in medicine, severe sepsis is a
common cause of admission to intensive care units with
mortality up to 54% reaching the third leading cause of
death in Germany [1].
Clincally mortality in severe sepsis is dichotomic with
mortality due to sequela of septic shock and multiorgan
failure in the first days and mortality due to secondary,
nosocomial infections later in the course of the disease.
An active response to bacterial antigens via activation
of immune cells leading to a cytokine response is neces-
sary for the clearance of invading pathogens, but an un-
controlled excessive production of pro-inflammatory
cytokines during infection such as tumor necrosis factor
(TNF)-α, seems to be responsible for the clinical mani-
festation of septic shock and the mortality in the first
days [2,3]. Later in sepsis an antigen hyporesponsive
state, the endotoxin tolerance in combination with
reduced apoptosis and reduced proliferative capacity is
seen and associated with increased nosocomial second
hit infections [4]. Bacterial antigen activates the innate
immune system via pattern recognition receptors (PRR’s)
on leucocytes and epithelial cells. It has been shown that
toll like receptors (TLR’s) and the triggering receptor
expressed on myeloid cells − 1 (Trem-1) seem to have a
crucial role in immune cell activation in infectious and
autoimmune diseases [5-10]. The secondary immuno-
suppressive state is caused by the initial antigen chal-
lenge. Following the phase of proinflammation, induction
of aniinflammatory molecules, such as IL-10, lead to a de-
activation of immune cells [2,3]. In a recent sepsis study we
were able to show in a late phase of human sepsis (day 3)
an association of TLR2 and CD14 expression on monocytes
with the cytokine hyporesponsiveness [11]. In addition to
the innate immunity with cytokine hyporesponsiveness a
decreased activity of the adaptive immunity with reduced
HLA-DR expression and antigen presentation is seen in
sepsis [12].
The role of Trem-1 in endotoxin tolerance has to be
defined [13]. Blockade of Trem-1 with antibodies or SI-
RNA before or after endotoxin challenge in experimental
murine infection influences the proinflammatory reac-
tion [14]. Incomplete antibody blockade or inhibition of
Trem-1 signalling reduced mortality without inhibiting
bacterial clearance [14,15], but complete blockade of
Trem-1 with SI-RNA decreased bacterial clearance and
increased mortality [16].
In this study we evaluated in a human E. coli sepsis co-
hort, the role of PRR including
TLR’s and Trem-1. We hypothesized that Trem-1 ex-
pression on neutrophils and/or monocytes associated
with endotoxin tolerance in severe bacterial sepsis.
The endotoxin hyporesponsiveness was tested in a
whole blood stimulation assay. We investigated theTLR2, TLR4, CD14, HLADR and Trem-1 expression on
blood neutrophils and monocytes of patients with E. coli
sepsis and healthy controls. To have an insight into the
functional activity of the receptor we correlated Trem-1
expression on neutrophils and monocytes in sepsis
patients with the cytokine release after stimulation with
LPS and LTA.Methods
Sepsis patients
A total number of 22 patients with a positive blood cul-
ture for Escherichia coli and sepsis (defined according
to [17]) were investigated in a prospective manner.
Patients below 18 years or with defined immunodefi-
ciency (hematologic or solid neoplasia, glucocorticoid
or cytotoxic therapy, HIV infection or immunoglobulin
deficiency) were excluded from the study.
The source of sepsis was the urinary tract (n = 20), the
lung (n = 1) and the gastrointestinal (n = 1). 17 out of 22
(77%) of the patients had a predisposing chronic disease
(pulmonary disease, cardiovascular disease, neurologic
disease, renal insufficiency, diabetes mellitus).Control group
Six unrelated healthy persons, all of white origin without
signs of inflammatory disease, served as a control group.
The study has been performed in compliance with the
Declaration of Helsinki and with the approval of the eth-
ics committee of the University Lübeck (AZ: 04-157).
Written informed consent was obtained from patients or
their relatives and healthy volunteersStudy protocol
Venous blood samples were obtained once in healthy
controls. In patients a blood sample was taken when a
positive blood culture for E coli was reported by the
microbiologist (24 to 48 hours after clinical diagnosis of
sepsis).Sepsis severity
Severe sepsis was defined as sepsis with organ dysfunc-
tion according to Bone et al. [17]. Septic shock was
defined as sepsis in combination with sepsis induced sys-
tolic blood pressure of < 90 mmHg for at least 30 min,
in the absence of other causes of shock, and at least 4 h
of inotropic support after adequate fluid replacement
[14]. For group comparison, patients with simple sepsis
were compared with patients with severe sepsis includ-
ing patients with septic shock and/or multiorgan failure
(MODS). In addition the acute physiology score (APS),
the APACHE II Score (including APS) and clinical/la-
boratory parameters were evaluated.
Table 1 Demographic and clinical data of 22 patients
with E coli sepsis







APACHE II * 16 ± 9,02
APS * 8,5 ± 7,3
Septic complications
Acute renal failure 5 (22,7%)
DIC * 4 (18,2%)
28 day mortality 7 (%)
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30 ml of blood was obtained by venepuncture and collected
into sterile heparinized tubes. PBMC were isolated by
Bicoll/Ficoll density gradient centrifugation. PBMCs were
cultured in 24-well tissue plates (Biochrome, Berlin,
Germany) using endotoxin-free RPMI 1640 medium
(Biowhittaker, Belgium) supplemented with 2 mM L-
glutamine (Gibco, Eggenstein, Germany) at a density of
0.5 × 106 cells/ml at 37°C in a 5% CO2 humidified atmos-
phere for a period of 3 h. The expression of Trem-1, TLR2,
TLR4 ,HLA-DR and CD14 on monocytes and TLR2, TLR-
4 and Trem-1 on neutrophils was determined using a fluor-
escence activated cell sorter (FACS Calibur, Becton
Dickinson, Heidelberg, Germany). Data acquisition and
analysis were performed with CellQuest software (Becton
Dickinson, Heidelberg, Germany). Each measurement
contained ≥ 10,000 cells in the monocyte population
determined by characteristic forward/orthogonal light
scattering in a density plot. PBMC (1 × 106) were incubated
on 4°C with 5 μl of following antibodies: anti-Trem-1, -
TLR2, -TLR4, -CD14 and –HLA-DR or isotype control
(eBioscience, San Diego, USA). The expression of surface
markers was calculated as mean fluorescence intensity
(MFI) since no bimodal distribution was found.
Whole blood stimulation
Whole blood stimulation assay was done as described
previously [18]. In brief, 2,5 mL of heparinized blood
was diluted 1:10 with RPMI 1640 (Biochrome, Berlin,
Germany) supplemented with Pen/Strep 1% (Gibco,
Germany) and immediately stimulated with 1 μg/mL
LPS from Escherichia coli serotype 026:B6 (Sigma, St.
Louis, USA) or with 100 μg/ml LTA from Stapylococcus
aureus (Sigma L2515, St. Louis, USA). Samples were
incubated in PPN tubes at 37°C with 5% CO2. Each ex-
periment also included controls without LPS or LTA.
Cell-free supernatants were removed after 24 h and
stored at −80°C until assayed.
Cytokine assay
IL-6, IL-8, IL-10 and TNF-α measurement of super-
natant from whole blood stimulation and from unstimu-
lated sera was performed using commercially available
enzyme-linked immunosorbent assay kits (Biosource,
Solingen, Germany).
Measurement of soluble Trem-1 (R&D Systems) and
Procalcitonin (Acris Antibodies, Germany) was performed
by enzyme-immuno-assay.
Statistics
Nonparametric statistics were used throughout the
study. Data are given as mean ± SD. The Wilcoxon
signed rank test was used for comparison of paired
samples, for comparisons of independent samples theMann–Whitney-U-test was used. Correlations were
made with the Spearman’s rank correlation. Calculations
were carried out with Statistica for Windows, version 5,
1997. A p value of < 0.05 was considered significant.
Results
Demographic data
Demographic data and parameter of sepsis severity
(APACH II, APS, septic complications and mortality) are
shown in Table 1. Mean age of the 22 patients was 72 -
years. Ten patients were male, 12 patients female. Sim-
ple sepsis was seen in 11 patients, severe sepsis in 6,
septic shock in 4 and MODS in 1 patient (Table 1).
TLR2, TLR4, CD14, HLA DR and Trem-1 cell expression of
sepsis patients compared to healthy controls
The monocytes expression of Trem-1 and TLR2 was sig-
nificant higher compared to healthy volunteers (p <
0.05). HLA-DR, CD14 and TLR4 expression showed no
significance (Figure 1).
The neutrophil expression of Trem-1 and TLR2 was sig-
nificant higher compared to healthy volunteers (p < 0.05).
TLR4 expression showed no significance (Figure 1).
TLR2, TLR4, CD14, HLA-DR and Trem-1 expression of
sepsis patients according to sepsis severity
The monocyte expression of Trem-1 (trend) and TLR2
(significant) are higher in patients with severe sepsis (in-
cluding septic shock and MODS) compared to patients
with simple sepsis (severe sepsis vs. simple sepsis: Trem-
1: 31,47 (±12) vs. 24.54 (±19,65); p = 0,07; TLR2: 27.57
(±8,59) vs. 22,08 (±8,3) p < 0,05) (Table 2).
The monocyte expression of HLA-DR was significantly
lower in patients with severe sepsis compared to simple
sepsis (5,216 (±4,17) vs. 10,38 (±5,03), p < 0,05).
Figure 1 A: Flow cytometry expression of TLR2, TLR4, CD14,
HLA-DR, Trem-1 on monocytes. MFI ± SD is shown for patients (P)
and healthy volunteers (V); * < 0,05; MFI = mean fluorescence
intensity. B: Flow cytometry expression of TLR2, TLR4, Trem-1 on
neutrophils. MFI ± SD is shown for patients (P) and healthy
volunteers (V); * < 0,05; MFI = mean fluorescence intensity.
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lower in patients with severe sepsis (severe sepsis vs.
simple sepsis: Trem-1: 19,5 (±7,33) vs 24,00 (±11,91); p
> 0,05).
No correlation was found between TLR-2, TLR-4, CD-
14, Trem-1, HLA-DR expression and APS, APACHE II,
Serum-CRP and Serum PCT values or death (data not
shown).Table 2 TLR2, TLR4, HLA-DR and Trem-1 expression on
blood cells according to sepsis severity
Simple sepsis Severe sepsis p
Monocytes
TLR2 22,08 (±8,3) 27,57 (±8,59) <0,05
TLR4 6,72 (±1,62) 6,0 (±1,38) >0,05
Trem-1 24,54 (±19,65) 31,47 (±12) >0,05
HLA-DR 10,38 (±5,03) 5,2 (±4,17) <0,05
Neutrophils
TLR2 14,63 (±6,84) 14,15 (±4,16) >0,05
TLR4 5,15 (±2,09) 4,56 (±0,96) >0,05
Trem-1 24,0 (±11,91) 19,5 (±7,33) >0,05Cytokine concentration in unstimulated serum
To evaluate the magnitude of cytokine blood levels
during sepsis, serum values of several cytokines and in-
flammatory markers were evaluated. TNF-α, PCT and
soluble Trem-1 (sTREM) values were significantly higher
(p < 0.05) in patients with severe sepsis compared to
simple sepsis (Table 3).
Cytokine inducibility in whole blood stimulation
To test the cytokine inducibility and a possible
hyporesponsiveness during sepsis, a whole blood assay
with LPS and LTA in vitro stimulation was used.
Hyporesponsiveness for LPS stimulation was seen in
patients with severe sepsis compared to simple sepsis
patients for IL6, IL8, IL10 and TNFα reaching significant
results for TNFα (Table 4).
Functional activity of Trem-1 on neutrophils
To test the functional activity of TLR2, TLR4, CD14 and
Trem-1, the cytokine inducibility after LPS and LTA
stimulation was correlated with the receptor expression.
In sepsis patients Trem-1 expression on neutrophils
was associated with the IL-10 (LPS: r = 0,61, p < 0.02)
and TNF-α inducibility (LPS: r = 0,78, p < 0,002)
(Figure 2). No correlation was found for the cytokine
inducibility with the expression of Trem-1, TLR2, TLR4,
CD14 or HLA-DR on monocytes (data not shown).
Association of trem-1 expression on neutrophils with
immune activation
In sepsis patients Trem-1 expression on neutrophils
shows a negative correlation to the serum levels of TNF-
α (r = −0,63; p < 0,005), IP-10 (r = −0,5; p < 0,035) and
procalcitonin (r = −0,59; p < 0,007) (Figure 3). No correl-
ation was found for IL-10.
No correlation was found for the cytokine serum levels
with the expression of Trem-1, TLR2, TLR4, CD14 or
HLA-DR on monocytes (data not shown).
Discussion
Our study demonstrates increased expression levels of
TLR2, TLR4, CD14 and Trem-1 protein expression on
blood monocytes of patients with E. coli sepsis.
An interesting association was found for the Trem-1
expression on blood neutrophils with the cytokineTable 3 Serum levels of TNF-α, PCT soluble Trem-1
(sTREM) and CRP according to sepsis severity
Simple sepsis Severe sepsis p
TNF-α (pg/ml) 5,62 (±1,91) 28,18 (±15,23) <0,05
PCT (ng/ml) 9,05 (±15,65) 80 (±89,4) <0,05
sTrem-1 (pg/m)l 347,9 (±182,1) 741 (±446,9) <0,05
CRP (mg/l) 153 (±27,21) 219 (±30,93) >0,05
Table 4 Cytokin inducibility in whole blood stimulation
for IL-6, Il-8, Il-10 and TNF-α
Simple sepsis Severe sepsis p
IL-6
LPS 14253 ± 10714 7200 ± 6823 > 0,05
LTA 15513 ± 9166 8871 ± 12318 > 0,05
IL-8
LPS 1515 ± 1026 1217 ± 1405 > 0,05
LTA 4735 ± 2925 2002 ± 2096 > 0,05
IL-10
LPS 15,55 ± 14,13 12,47 ± 11.83 > 0,05
LTA 33,83 ± 17,85 13,27 ± 12,50 > 0,05
TNF-α
LPS 760,6 ± 745,4 325,2 ± 623,8 < 0,01
LTA 1530 ± 1820 239,5 ± 381,5 < 0,01
Figure 2 A: Correlation between Trem-1 expression on
neutrophils and LPS induced inducibility of IL10. B: Correlation
between Trem-1 expression on neutrophils and LPS induced
inducibility of TNF-α.
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associated with low cytokine inducibility after stimula-
tion with bacterial antigen. Trem-1 receptor on
neutrophils might be involved in the induction of
cytokines during sepsis [19]. Low Trem-1 expression on
neutrophils might be associated with hyporesponsiveness
during severe human sepsis.
The host defence needs to detect invasion of patho-
genic organism to induce an inflammatory response in
order to control the infection. Pathogen recognition
receptors (PRR) as TLR’s and CD14 are activated via
pathogen associated molecular pattern, namely LPS for
gram negative and LTA for gram positive bacteria. The
activation of the immune cells causes via induction of
gene transcription the production of cytokines.
Trem-1 is a relatively new discovered receptor expressed
on neutrophils and monocytes, also involved in the innate
immune response to bacterial pathogens [13,14]. Activa-
tion of Trem-1 together with TLR ligands as LPS or LTA
causes increased production of TNFα [20,21]. It has been
shown that in patients with sepsis and in mice with
experimental LPS induced septic shock, Trem-1 is
upregulated on neutrophils [14]. In line with this data,
Trem-1 was upregulated on neutrophils and monocytes in
our study (Figure 1). On the other hand, activation of
Trem-1 and TLR4 caused a reduction of the production
of the antiinflammtory cytokine IL-10 [21].
In patients with severe E. coli sepsis we found a trend
towards lower Trem-1 on neutrophils but higher soluble
Trem-1 (compared to patients with simple sepsis,
Table 4). This data are in line with recent data from Oku
et al., who have shown reduced Trem-1 on neutrophils
but increase soluble Trem-1 in sepsis patients compared
to SIRS patients [9]. A correlation between soluble
Trem-1 and sepsis severity has also been shown in re-
cent papers [22-24].Why do we and others find a differential pattern in
sepsis with high soluble Trem-1 and low neutrophil-
surface TREM-1? Monocyte surface Trem-1 is shed by a
metalloprotease [25]. Pina et al. speculate that surface
TREM-1 might also be shed from neutrophils explaining
low surface Trem-1 in severe sepsis [25].
Figure 3 A: Correlation between neutrophil Trem-1 expression
and serum IP-10 concentration (p < 0,035, R = −0,5). B: Correlation
between neutrophil Trem-1 expression and Serum TNFα concentration
(p < 0,005, R = −0,63). C: Correlation between neutrophil Trem-1
Expression and Serum PCT concentration (p < 0,007, R = −0,59).
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capacity to produce cytokines. We found a positive
correlation between Trem-1 expression on neutrophils
and cytokine inducibility. Low Trem-1 expression on
neutrophils was associated with low cytokine production
after stimulation. In addition we found a negative correl-
ation of Trem-1 on neutrophils and markers of immune
activation. The higher levels of TNF-α in serum were
found, the lower Trem-1 expression on neutrophils was
measured. Since surface Trem-1 is activated early during
sepsis [14] and downregulated during severe sepsis, a
negative loop might exist.
Our result might be interesting for the phenomenon
of endotoxin hyporesponsiveness during sepsis [26,27].
Sepsis can induce monocyte hyporesponsiveness,
causing an anergic state of the immunesystem to gram
negative and gram positive bacteria [26]. Patients with
hyporesponsiveness are immunosuppressed, and are
prone to secondary infections associated with increased
morbidity and mortality [26-28]. In our study we can
show a hyporesonsiveness in severe sepsis seen as
reduced TNF inducibility (Table 4) to E. coli endotoxin
and to S. aureus antigen (lipotheichonic acid, LTA). Since
reduced surface Trem-1 on neutrophils was associated
with reduced TNF inducibility, surface Trem-1 on
neutrophils might be involved in hyporesponsiveness.
In addition to above data, as shown before, HLA-DR
expression on monocytes was decreased in severe sepsis,
probably influencing the capacity of antigen presentation
[29].
Beside a negative effect with immunosuppression,
some data show a protective effect of Trem-1 inhibition
via reduction of the overwhelming toxic proinflammation
during septic shock. Bouchon et al. were able to show
a protective effect of antibody blockade of Trem-1 in
Mice [14]. Injection of antibody 1 hour before endo-
toxin challenge was protective and caused reduction in
mortality from 94 to 24%. The same effect was seen in
experimental E. coli sepsis in mice [14]. The effect was
less pronounced when antibodies were given after the
endotoxin injection. On the other hand complete silen-
cing of Trem-1 via SI-RNA decreased bacterial clear-
ance and increased mortality in a mouse model of
infection [16]. Partial inhibition of Trem-1 in the bac-
terial peritonitis model produced a significant survival
benefit [16]. Downregulation of the cytokine produc-
tion during severe human sepsis might have a protect-
ive effect reducing the dangers of overwhelming
cytokine production in the beginning and a detrimental
effect later on since immunosuppression increase the
risk of secondary infections [30]. Hyporesponiveness
might protect the person of overwhelming cytokine
production but increases the risk of secondary
infections.
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were only measured at sepsis diagnosis (transversal
study), serial evaluation (longitudinal study) was not
performed. Since the study population was small, more
subjects are required for future trials. Newly discovered
factors (e.g. Trem-2, Trem-like transcript 1 and 2) might
also be involved.
Conclusions
Patients with severe E. coli sepsis compared to patients
with simple sepsis are characterized by endotoxin toler-
ance and cytokine hyporesponsiveness.
Trem-1 on blood neutrophils is tendentially lower in
patients with severe sepsis, associated with reduced cyto-
kine inducibility.
Since Trem-1 has been discussed as a potential thera-
peutic target in sepsis [30], the precise role in inflamma-
tory response to bacterial infection of soluble and
surface bound Trem-1 on neutrophils and monocytes
should be further evaluated in clinical and experimental
studies.
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